TL;DR

  • Topical up to 2% on limited areas (face, upper back) – safe throughout pregnancy.
  • Peels above 2%, large areas, prolonged courses – avoid.
  • Wart and callus removers at 10-40% – do not apply to large skin areas without medical consultation.
  • High-dose oral aspirin – contraindicated in the third trimester; in T1-T2 only under strict indications.
  • Low-dose aspirin 75-150 mg for preeclampsia prevention is a separate prescription from the obstetrician.

First-line pregnancy alternatives: azelaic acid 15-20%, glycolic acid 5-8%, niacinamide 5-10%, benzoyl peroxide 2.5-5% in short courses.

What salicylic acid is

Salicylic acid is a beta-hydroxy acid (BHA). Unlike alpha-hydroxy acids (AHA: glycolic, lactic) it is oil-soluble and penetrates sebaceous glands. This makes it the key agent against acne: it breaks up follicular plugs and reduces inflammation.

Three formats with fundamentally different concentrations:

  • Home-use cosmetics: 0.5-2% in lotions, toners, cleansing gels, spot treatments.
  • In-office peels: 10-30%, single session lasting a few minutes.
  • Keratolytic preparations: 10-40% in callus, wart, and rough-skin products.

Full ingredient breakdown – on the salicylic acid card.

What the pregnancy guidelines say

The American Academy of Dermatology (AAD) 2024 and the Spanish Society of Gynecology and Obstetrics SEGO 2023 agree: topical salicylic acid up to 2% on limited skin areas (face, upper back, chest) during pregnancy is safe. This is supported by clinical data and the relatively low systemic absorption in this dosing.

Things get complicated with high concentrations and large areas. Systemic absorption rises, and salicylic acid is pharmacologically related to aspirin (acetylsalicylic acid). High-dose oral aspirin in the third trimester is contraindicated – it raises the risk of premature ductus arteriosus closure and labor bleeding. As a precaution the guidelines do not recommend:

  • salicylic peels above 2% during pregnancy;
  • wart and callus removers at 10-40% on large skin areas;
  • regular use of 3% salicylic acid anti-dandruff shampoos over the full scalp and shoulders.

Trimester-by-trimester rules

T1 (weeks 1-12)

Organogenesis. Any systemic absorption carries maximum risk. What's allowed:

  • Spot application of 0.5-2% lotion to inflammatory lesions.
  • Cleansing gels with 0.5-2% if rinsed off within a minute.
  • Toners with 0.5-1% on the face.

What to avoid:

  • Any in-office salicylic acid peels.
  • Large skin areas (entire face plus back plus chest at once).
  • 2% salicylic acid masks on the full face.

T2 (weeks 13-27)

The window with the lowest skin reactivity and best tolerance. Same rules as T1. In-office peels still postponed.

T3 (week 28 to delivery)

The strictest restrictions due to theoretical impact on the fetal ductus arteriosus and platelet function. Only retained:

  • Spot application of 0.5-2% to isolated inflammatory lesions.

Other uses are postponed, including daily toner on the full face.

Pregnancy alternatives

For acne, post-acne pigmentation, or oily skin there are options with stronger pregnancy safety data.

Azelaic acid 15-20% – first-line in pregnancy (FDA category B). Effective for inflammatory acne, rosacea, and hyperpigmentation. AAD 2024 data show comparable efficacy to 2% salicylic acid and 0.1% adapalene without pregnancy restrictions.

Glycolic acid 5-8% – a mild AHA, acceptable topically at cosmetic concentrations. Without irritation and with proper SPF protection it delivers a similar texture effect without systemic risk. High concentrations (10%+) and peels are postponed.

Niacinamide 5-10% – vitamin B3, safe in any trimester. Reduces sebum, calms inflammation, evens skin tone. One of the safest active ingredients in pregnancy – see the niacinamide card.

Benzoyl peroxide 2.5-5% in short courses – accepted by AAD 2024 and SEGO 2023 consensus for limited-area use. Systemic absorption is minimal and it sits in FDA category C based on absence of demonstrated human harm.

Pregnancy acne management

Pregnancy acne is common and driven by hormonal changes. In T1, 40-50% of pregnant women see worsening or new-onset acne. In 20-30% these changes last the full term.

The AAD 2024 base regimen:

  1. Daily gentle cleansing with 0.5-2% salicylic acid or azelaic acid gel. Rinse within a minute.
  2. Morning: niacinamide 5-10% or azelaic acid 15-20% plus SPF 30+ with mineral filters or Tinosorb S.
  3. Evening: azelaic acid 15-20% or 2.5-5% benzoyl peroxide spot-applied to inflammatory lesions.
  4. For pronounced inflammation – discuss topical erythromycin or clindamycin with a dermatologist (category B). All systemic retinoids and tetracyclines are off-limits.

For severe pregnancy acne with cystic lesions, dermatology consultation is mandatory and may include in-office options safe in pregnancy (e.g., 1450 nm laser).

What's off-limits in pregnancy regardless of area

Items the guidelines explicitly prohibit:

  • Oral isotretinoin (Accutane, Roaccutane) – FDA category X, absolute contraindication.
  • Topical tretinoin and adapalene – theoretical systemic absorption risk; AAD and SEGO recommend avoidance.
  • Oral tetracyclines (doxycycline) – after T1 cause tooth staining and bone growth abnormalities.
  • Spironolactone – antiandrogen, contraindicated in pregnancy.
  • Hormonal contraceptives for acne – naturally not used.

Bottom line

Topical salicylic acid up to 2% on limited skin areas is a safe ingredient in pregnancy. Peels, high-concentration wart treatments, large-area application, and regular salicylic shampoos are postponed until after delivery and lactation.

For pregnancy acne and post-acne pigmentation, first-line is azelaic acid, niacinamide, and benzoyl peroxide with SPF 50+. If the skin reacts with pronounced inflammation, topical antibiotics and in-office options should be discussed with a dermatologist.

Authors: Evigrade editorial team with Victoria Gankova, MD. Sources: AAD Guidelines for Acne 2024, SEGO Documento de Consenso 2023, ACOG Practice Bulletin 2019 reaffirmed 2024.